News Sentiment

VALN sentiment intelligence

Valneva SE ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.05 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

77/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-3.3% over one week, -5.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Behavioral Patterns of VALN and Institutional Flows

Market Reaction

Balanced read

57/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 77/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend inactive -5.7% over four weeks
Fair value -38.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 37
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 10
Market source 7
GlobeNewswire 6
Stock Traders Daily 5
Stock Titan 5
TradingKey 4
The National Law Review 3
Seeking Alpha 3

Event Lens

What the news is about

Classified themes
Earnings 30
Market update 24
Analyst action 3
Regulatory and legal 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 60
Stock Traders Daily Direct company coverage

Behavioral Patterns of VALN and Institutional Flows

The article analyzes Valneva SE (NASDAQ: VALN), noting a near-term weak sentiment that may lead to long-term weakness, despite a neutral shift. It highlights an exceptional 182.0:1 risk-reward setup targeting a 39.2% gain versus a 0.2% risk. The analysis also provides specific in

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 00:12
Source
Stock Traders Daily
ad-hoc-news.de Direct company coverage

Ixiaro by Valneva SE - Japanese encephalitis shot for serious travelers

This article provides an in-depth look at Ixiaro, Valneva's inactivated Japanese encephalitis vaccine. It details the vaccine's target demographic, dosing schedule, safety profile, regulatory approvals, and its strategic position within Valneva's vaccine portfolio. The article al

Tone
Positive 66/100
Event
Analyst action
Published
11 Jul 2026 06:39
Source
ad-hoc-news.de
TradingView Direct company coverage

ETFs Investing in Valneva SE Stocks

This article lists several ETFs that hold Valneva SE stocks, providing information such as market value, weight, issuer, management style, focus, expense ratio, AUM, price change, relative volume, and 3-year NAV total return for each ETF. The ETFs primarily focus on genomics, imm

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 19:39
Source
TradingView
AD HOC NEWS Direct company coverage

The Ixiaro vaccine - Valneva bets on niche travel protection

Valneva's Ixiaro vaccine targets travelers and military personnel at risk of Japanese encephalitis in Asia-Pacific regions. The article details the vaccine's design, efficacy, market positioning, and regulatory approvals, emphasizing its role within Valneva's specialized travel v

Tone
Positive 71/100
Event
Regulatory and legal
Published
08 Jul 2026 15:03
Source
AD HOC NEWS
TradingView Direct company coverage

Price to earnings forward of Valneva SE – EURONEXT:VLA

This page provides financial information for Valneva SE (EURONEXT:VLA), specifically focusing on its forward price-to-earnings ratio. The content is presented within the TradingView platform, noting that the market was closed and no trades were made at the time of viewing. It app

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 21:10
Source
TradingView
Stock Traders Daily Direct company coverage

(VALN) Movement Within Algorithmic Entry Frameworks

The article analyzes Valneva SE (NASDAQ: VALN) using algorithmic entry frameworks. It notes stable neutral readings in shorter horizons, potentially easing a long-term weak bias, and highlights an exceptional 192.0:1 risk-reward setup targeting a 39.6% gain. Three distinct tradin

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:04
Source
Stock Traders Daily
The National Law Review Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Valneva SE (VALN) purchasers following a significant drop in its American Depositary Receipt (ADR) price. This decline occurred after Valneva and Pfizer announced topline results from their Phase 3

Tone
Negative 30/100
Event
Earnings
Published
02 Jul 2026 08:09
Source
The National Law Review
The National Law Review Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Valneva SE (NASDAQ: VALN) after its American Depositary Receipt (ADR) price dropped significantly following the announcement of Phase 3 clinical trial results for its Lyme disease vaccine candidate. The

Tone
Negative 20/100
Event
Earnings
Published
30 Jun 2026 15:09
Source
The National Law Review
TradingView Direct company coverage

AYJ0 Forecast — Price Target — Prediction for 2027

This article provides the forecast and price target for Valneva SE Sponsored ADR (AYJ0) on the Frankfurt Stock Exchange. Based on 10 analysts' 1-year price forecasts, the price target is 11.28. The article also touches on EPS and revenue metrics, alongside a disclaimer about inve

Tone
Neutral 50/100
Event
Earnings
Published
30 Jun 2026 06:40
Source
TradingView
www.marketscreener.com Direct company coverage

Certain Ordinary Shares of Valneva SE are subject to a Lock-Up Agreement Ending on 30-JUN-2026.

Certain ordinary shares of Valneva SE are under a lock-up agreement set to end on June 30, 2026. The lock-up period for these shares is 61 days, starting from April 30, 2026, and applies to the company’s board members and executive officers in connection with a Reserved Offering.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 00:40
Source
www.marketscreener.com
The National Law Review Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Valneva SE (NASDAQ:VALN) on behalf of investors. This investigation follows a significant drop in Valneva's ADR price after its Lyme disease vaccine candidate, developed with Pfizer, failed to meet its p

Tone
Negative 29/100
Event
Regulatory and legal
Published
28 Jun 2026 14:09
Source
The National Law Review
TradingView Direct company coverage

A3CPD1 Forecast — Price Target — Prediction for 2027

This page provides a forecast and price target for Valneva SE Sponsored ADR (A3CPD1) for 2027. Ten analysts have provided 1-year price forecasts, although the maximum and minimum estimates are not displayed. The page also touches on analyst ratings, EPS, and revenue metrics.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 22:41
Source
TradingView
Simply Wall Street Direct company coverage

VLA: Travel Vaccine Headwinds Will Set Up Future Repricing Potential

Analysts have reduced their fair value estimate for Valneva (VLA) by 25% to €5.23 per share, primarily due to updated assumptions for discount rate, revenue growth, profit margin, and future P/E levels. This adjustment comes amidst Valneva lowering its 2026 earnings and sales gui

Tone
Negative 30/100
Event
Earnings
Published
27 Jun 2026 18:09
Source
Simply Wall Street
TradingView Direct company coverage

Valneva SE Sponsored ADR Actuals & Estimates (NASDAQ:VALN)

This page provides financial actuals and estimates for Valneva SE (NASDAQ:VALN), allowing users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. It highlights the ability to compare actual results with average, hi

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:10
Source
TradingView
Seeking Alpha Direct company coverage

Valneva SE (VALN) Shareholder/Analyst Call - Slideshow (NASDAQ:VALN)

This article announces that Valneva SE (VALN) published a slide deck in conjunction with a shareholder/analyst call. The content is primarily a placeholder for the accompanying slideshow, indicating that further details would be found within the provided slides. The article was w

Tone
Positive 72/100
Event
Analyst action
Published
26 Jun 2026 05:10
Source
Seeking Alpha
TradingView Direct company coverage

VALN Forecast — Price Target — Prediction for 2027

This article provides a brief forecast for Valneva SE (VALN), including its price target and analyst ratings. Based on 10 analysts, the 1-year price forecast is $12.88. The article also touches upon EPS and revenue metrics, advising that the content is not investment advice.

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 03:41
Source
TradingView
Moomoo Direct company coverage

Press Release: Valneva Announces Successful Outcome of Its Annual General Meeting

Valneva SE announced the successful outcome of its Annual General Meeting held on June 28, 2024, in Lyon, France. Shareholders approved all proposed resolutions, including the re-election of Deloitte & Associés as statutory auditor, the appointment of a new independent director,

Tone
Positive 73/100
Event
Market update
Published
25 Jun 2026 18:09
Source
Moomoo
TradingView Direct company coverage

VLA Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Valneva SE (VLA) stock, based on analysis from 10 financial analysts. It details the company's current stock price, recent performance trends, and financial metrics such as earnings per share, revenue, and market capitalizatio

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 16:41
Source
TradingView
Stock Titan Direct company coverage

Valneva (Nasdaq: VALN) holders approve AGM items and elect new chair

Valneva SE shareholders approved all Board-recommended resolutions at its Annual General Meeting, including the 2025 financial statements and the transfer of its registered office to Lyon. Dr. Gerd Zettlmeissl was appointed as the new Chair of the Board of Directors, succeeding A

Tone
Positive 61/100
Event
Market update
Published
25 Jun 2026 15:40
Source
Stock Titan
TradingKey Direct company coverage

Valneva SE (VALN) Financial Health: Profitability & Balance Sheet Analysis

Valneva SE (VALN) has a financial score of 7.31, ranking 127 out of 387 in the Biotechnology & Medical Research industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue decreased by 34.74% year-over-year to $36.30M, and it

Tone
Negative 36/100
Event
Earnings
Published
25 Jun 2026 10:40
Source
TradingKey
TradingView Direct company coverage

Price to earnings forward of Valneva SE – OTC:INRLF

This page from TradingView displays "Price to earnings forward" data for Valneva SE (OTC: INRLF). The content is primarily a navigation-heavy interface for financial data, indicating that the specific financial metric for Valneva SE is accessible through this platform. The curren

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 08:40
Source
TradingView
Stock Traders Daily Direct company coverage

How (VALN) Movements Inform Risk Allocation Models

This article analyzes Valneva Se (VALN) stock movements, suggesting that strong near-term sentiment might challenge persistent mid and long-term weakness. It highlights an exceptional risk-reward setup targeting a 38.8% gain and outlines three AI-generated trading strategies with

Tone
Positive 69/100
Event
Market update
Published
21 Jun 2026 21:52
Source
Stock Traders Daily
aktiencheck.de Direct company coverage

Valneva’s Credibility Test: Stock Near Lows as Lyme Vaccine Data Gives Conflicting Signals

Valneva's stock is near its 52-week low, battered by conflicting data from its Lyme vaccine candidate, LB6V, developed with Pfizer, which failed its primary statistical endpoint in a Phase 3 study. The company is facing a skeptical shareholder base ahead of its annual general mee

Tone
Negative 29/100
Event
Market update
Published
20 Jun 2026 12:39
Source
aktiencheck.de
TradingKey Direct company coverage

Valneva SE (VALN) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a detailed timeline of Valneva SE's (VALN) dividend history and stock split events. It indicates that Valneva SE has not distributed any dividends over the past five years and has no recorded stock splits. The page serves as a financial data reference from Tr

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 13:40
Source
TradingKey
TradingKey Direct company coverage

Valneva SE (VALN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Valneva SE (VALN) based on its business segments and regional contributions. As of April 6, the company's main revenue drivers are IXIARO and DUKORAL, with significant contributions from the United States and Canada. The data

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 02:39
Source
TradingKey
TradingKey Direct company coverage

Valneva SE (VALN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Valneva SE (VALN) has an earnings forecast score of 8.00, placing it 163rd in the Biotechnology & Medical Research industry. Analysts have an average price target of $13.00 for VALN, with a majority recommending a "Buy" rating. The company's expected revenue for the next quarter

Tone
Positive 71/100
Event
Earnings
Published
17 Jun 2026 12:10
Source
TradingKey
Stock Titan Direct company coverage

[EFFECT] Valneva SE SEC Filing

This article reports on Valneva SE's SEC filing of Form EFFECT, indicating the effectiveness of their F-3 registration statement. The filing, dated June 16, 2026, involves the company Valneva SE (NASDAQ: VALN) and provides details regarding its market capitalization, industry, an

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 10:10
Source
Stock Titan
AD HOC NEWS Direct company coverage

Protective clarity for your vaccine shares with the Valneva SE investor focus

This article provides an investor focus on Valneva SE (ISIN FR0013280286), a company specializing in prophylactic vaccines. It offers shareholders a concise overview of the company's stock context, pipeline, and how to track relevant news and financial data. The article emphasize

Tone
Positive 68/100
Event
Market update
Published
17 Jun 2026 03:10
Source
AD HOC NEWS